Harbor BioSciences(HRBR)
$2.400.00 (0.00%)
HRBR
Harbor BioSciences financials statements
$2.40
At close:0.00 (0.00%)
Harbor BioSciences (HRBR) Ratios
19 Followers
Harbor BioSciences Ratios
HRBR's free cash flow for Q4 2025 was $-14.21M. For the 2025 fiscal year, HRBR's free cash flow was decreased by $-1.46M and operating cash flow was $-12.75M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | ― | 4.40 | 3.88 | 2.16 |
| Quick Ratio | 0.00 | ― | 4.24 | 3.81 | 2.10 |
| Cash Ratio | 0.00 | ― | 0.72 | 0.50 | 0.41 |
| Solvency Ratio | 0.00 | ― | 0.16 | 0.47 | 0.66 |
| Operating Cash Flow Ratio | -2.61 | ― | -0.41 | 0.68 | 1.05 |
| Short-Term Operating Cash Flow Coverage | -50.08 | ― | 0.00 | 4.92 | 8.54 |
| Net Current Asset Value | $ -6.22M | ― | $ 68.00M | $ 118.02M | $ 13.66M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | ― | 0.05 | 0.20 | 0.22 |
| Debt-to-Equity Ratio | 0.01 | ― | 0.07 | 0.31 | 0.40 |
| Debt-to-Capital Ratio | 0.01 | ― | 0.06 | 0.24 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.00 | ― | 0.02 | 0.22 | 0.23 |
| Financial Leverage Ratio | 0.00 | ― | 1.34 | 1.57 | 1.83 |
| Debt Service Coverage Ratio | 0.00 | ― | 636.87 | 7.34 | 10.11 |
| Interest Coverage Ratio | 0.00 | ― | -2458.07 | 18622.00 | 124.17 |
| Debt to Market Cap | 0.01 | ― | 0.05 | 0.80 | 0.69 |
| Interest Debt Per Share | 0.02 | ― | 0.28 | 1.65 | 1.63 |
| Net Debt to EBITDA | 0.00 | ― | -1.38 | 0.52 | 0.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | ― | -7.79% | 25.23% | 26.17% |
| EBIT Margin | 0.00% | ― | -9.71% | 19.89% | 48.02% |
| EBITDA Margin | 0.00% | ― | 3.11% | 29.26% | 58.75% |
| Operating Profit Margin | 0.00% | ― | -18.51% | 19.89% | 42.48% |
| Pretax Profit Margin | 0.00% | ― | -9.71% | 19.26% | 47.68% |
| Net Profit Margin | 0.00% | ― | -8.02% | 13.92% | 37.41% |
| Continuous Operations Profit Margin | 0.00% | ― | -8.02% | 13.92% | 37.41% |
| Net Income Per EBT | 100.00% | ― | 82.61% | 72.29% | 78.47% |
| EBT Per EBIT | 0.00% | ― | 52.48% | 96.84% | 112.25% |
| Return on Assets (ROA) | 0.00% | ― | -6.76% | 10.22% | 23.19% |
| Return on Equity (ROE) | 0.02% | ― | -9.05% | 16.00% | 42.34% |
| Return on Capital Employed (ROCE) | 0.00% | ― | -17.78% | 17.65% | 34.00% |
| Return on Invested Capital (ROIC) | 0.00% | ― | -14.34% | 12.21% | 25.35% |
| Return on Tangible Assets | 0.00% | ― | -6.92% | 10.36% | 23.50% |
| Earnings Yield | 0.03% | ― | -17.79% | 39.61% | 82.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | ― | 31.40 | 24.60 | 33.36 |
| Payables Turnover | 0.00 | ― | 17.34 | 10.41 | 9.11 |
| Inventory Turnover | 0.00 | ― | 44.64 | 45.86 | 35.15 |
| Fixed Asset Turnover | 0.00 | ― | 2.31 | 2.43 | 1.73 |
| Asset Turnover | 0.00 | ― | 0.84 | 0.73 | 0.62 |
| Working Capital Turnover Ratio | 0.00 | ― | 1.38 | 1.91 | 2.73 |
| Cash Conversion Cycle | 0.00 | ― | -1.25 | -12.25 | -18.73 |
| Days of Sales Outstanding | 0.00 | ― | 11.63 | 14.84 | 10.94 |
| Days of Inventory Outstanding | 0.00 | ― | 8.18 | 7.96 | 10.38 |
| Days of Payables Outstanding | 0.00 | ― | 21.05 | 35.05 | 40.06 |
| Operating Cycle | 0.00 | ― | 19.80 | 22.80 | 21.33 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.55 | ― | -0.27 | 0.97 | 1.73 |
| Free Cash Flow Per Share | -0.55 | ― | -0.37 | 0.85 | 1.67 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | ― | -2.07 | 7.14 | 21.27 |
| Capital Expenditure Coverage Ratio | 0.00 | ― | -2.68 | 8.17 | 25.90 |
| Operating Cash Flow Coverage Ratio | -24.73 | ― | -0.98 | 0.59 | 1.07 |
| Operating Cash Flow to Sales Ratio | 0.00 | ― | -0.06 | 0.16 | 0.38 |
| Free Cash Flow Yield | -33.50% | ― | -18.38% | 40.02% | 80.94% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 3300.00 | ― | -5.23 | 2.57 | 1.22 |
| Price-to-Sales (P/S) Ratio | 0.00 | ― | 0.45 | 0.35 | 0.45 |
| Price-to-Book (P/B) Ratio | 0.61 | ― | 0.51 | 0.40 | 0.51 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.99 | ― | -5.44 | 2.50 | 1.24 |
| Price-to-Operating Cash Flow Ratio | -2.99 | ― | -7.47 | 2.19 | 1.19 |
| Price-to-Earnings Growth (PEG) Ratio | -32.95 | ― | 0.04 | -0.05 | 0.01 |
| Enterprise Value Multiple | 0.00 | ― | 13.14 | 1.73 | 1.12 |
| Enterprise Value | 97.72M | ― | 81.30M | 141.85M | 162.58M |
| EV to EBITDA | 0.00 | ― | 13.14 | 1.73 | 1.12 |
| EV to Sales | 0.00 | ― | 0.41 | 0.51 | 0.66 |
| EV to Free Cash Flow | -3.03 | ― | -4.92 | 3.59 | 1.79 |
| EV to Operating Cash Flow | -3.03 | ― | -6.76 | 3.15 | 1.73 |
| Tangible Book Value Per Share | -0.11 | ― | 3.89 | 5.16 | 3.93 |
| Shareholders’ Equity Per Share | 2.72 | ― | 4.01 | 5.27 | 4.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | ― | 0.17 | 0.28 | 0.22 |
| Revenue Per Share | 0.00 | ― | 4.52 | 6.06 | 4.56 |
| Net Income Per Share | 0.00 | ― | -0.36 | 0.84 | 1.71 |
| Tax Burden | 1.00 | ― | 0.83 | 0.72 | 0.78 |
| Interest Burden | 0.00 | ― | 1.00 | 0.97 | 0.99 |
| Research & Development to Revenue | 0.00 | ― | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | ― | 0.00 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | ― | 0.00 | 0.00 | 0.00 |
| Income Quality | -1076.63 | ― | 0.75 | 1.15 | 1.02 |
Currency in USD

